Retinoic acid selectively inhibits the vascular permeabilizing effect of VPF/VEGF, an early step in the angiogenic cascade

Microvascular Research

Volumn 60, Issue 2, 2000, Pages 112-120

  Pal, Soumitro ^a   Iruela Arispe, M Luisa ^b   Harvey, V Susan ^a   Zeng, Huiyan ^a   Nagy, Janice A ^a   Dvorak, Harold F ^a   Mukhopadhyay, Debabrata ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Angiogenesis; CAM assay; cGMP; Miles assay; PLC ; Retinoic acid (RA); Vascular permeability factor vascular endothelial growth factor (VPF VEGF)

Indexed keywords

ALITRETINOIN; FIBROBLAST GROWTH FACTOR 2; ISOTRETINOIN; RECOMBINANT VASCULOTROPIN; RETINOIC ACID; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; BLOOD VESSEL PERMEABILITY; CANCER INHIBITION; CELL DIFFERENTIATION; CHORIOALLANTOIS; CYTOKINE RELEASE; DRUG MECHANISM; DRUG SELECTIVITY; GUINEA PIG; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; NONHUMAN; PRIORITY JOURNAL; TRANSCRIPTION REGULATION;

ANIMALIA; CAVIA PORCELLUS; SUS SCROFA;

EID: 0033847196     PISSN: 00262862     EISSN: None     Source Type: Journal    
DOI: 10.1006/mvre.2000.2246     Document Type: Article

References (42)

1. Vitamin A effect on tumor angiogenesis
2. The retinoid revolution
3. Vascular endothelial growth factor up-regulates nitric oxide synthase expression in endothelial cells
4. 2+ and von Willebrand factor release in human endothelial cells
5. Vascular permeability factor/vascular endothelial growth factor: A multifunctional angiogenic cytokine
6. Keratinocyte-derived vascular permeability factor (vascular endothelial growth factor) is a potent mitogen for dermal microvascular endothelial cells
7. Vascular permeability factor/vascular endothelial growth factor and the significance of microvascular hyperpermeability in angiogenesis
8. Induction of a fibrin-gel investment: An early event in line 10 hepatocarcinoma growth mediated by tumor-secreted products
9. Vascular endothelial growth factor: Molecular and biological aspects
10. Cell proliferation and differentiation
11. Hypoxia induces permeability in brain microvessel endothelial cells via VEGF and NO
12. Vascular endothelial growth factor signals endothelial cell production of nitric oxide and prostacyclin through flk-1/KDR activation of c-Src
13. Retinoids and human cancer
14. Inhibition of angiogenesis through modulation of collagen metabolism
15. Angiogenesis: A dynamic balance of stimulators and inhibitors
16. Beta-interferon inhibits HIV-1 Tat-induced angiogenesis: Synergism with 13-cis retinoic acid
17. Introduction: Retinoic acid and its receptors in development
18. Inhibitory effects of retinoids on vascular endothelial growth factor production by cultured human skin keratinocytes
19. Effect of steroid hormones and retinoids on the formation of capillary-like tubular structures of human microvascular endothelial cells in fibrin matrices is related to urokinase expression
20. Effects of retinoids on endothelial cell proliferation, prostacyclin production and platelet aggregation
21. In vivo inhibition of angiogenesis and induction of apoptosis by retinoic acid in squamous cell carcinoma
22. Inhibition of squamous cell carcinoma angiogenesis by direct interaction of retinoic acid with endothelial cells
23. Retinoic acid and interferon alpha act synergistically as antiangiogenic and antitumor agents against human head and neck squamous cell carcinoma
24. Retinoids, interferon alpha, 1,25-dihydroxyvitamin D3 and their combination inhibit angiogenesis induced by non-HPV-harboring tumor cell lines. RAR alpha mediates the antiangiogenic effect of retinoids
25. Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group
26. Nitric oxide mediates mitogenic effect of VEGF on coronary venular endothelium
27. Nitric oxide synthase modulates angiogenesis in response to tissue ischemia
28. Vascular endothelial growth factor/vascular permeability factor enhances vascular permeability via nitric oxide and prostacyclin
29. A highly potent antiangiogenic activity of retinoids
30. Three novel synthetic retinoids, Re 80, Am 580 and Am 80, all exhibit anti-angiogenic activity in vivo
31. Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells
32. Nitric oxide is an upstream signal of vascular endothelial growth factor-induced extracellular signal-regulated kinase 1/2 activation in postcapillary endothelium
33. Modulation of bovine microvascular endothelial cell proteolytic properties by inhibitors of angiogenesis
34. Retinoid and carotenoid angiogenesis: A possible explanation for enhanced oral carcinogenesis
35. Fibroblast growth factor-2 (FGF-2) induces vascular endothelial growth factor (VEGF) expression in the endothelial cells of forming capillaries: An autocrine mechanism contributing to angiogenesis
36. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid
37. VEGF modulates NO production: The basis of a cytoprotective effect?
38. Biology and treatment of acute progranulocytic leukemia
39. Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor
40. Overexpression of retinoic acid receptor beta in head and neck squamous cell carcinoma cells increases their sensitivity to retinoid-induced suppression of squamous differentiation by retinoids
41. VEGF induces NO-dependent hyperpermeability in coronary venules